A year ago, Harvard Bioscience was on the fast track to growth. The company was growing revenues and expanding its reach through a series of acquisitions that created a diverse portfolio of companies providing tools to basic research, the clinical market, and drug discovery.

The stock price of the Holliston, Mass.-based laboratory equipment company grew to a high of $10.73 on Feb. 18, 2004, from a low of $3.00 on April 10, 2003.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.